Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(38%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
2
25%
Ph phase_3
3
38%
Ph phase_4
3
38%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Recruiting2
Active, not recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 33 (37.5%)
Phase 43 (37.5%)

Trials by Status

active_not_recruiting113%
recruiting225%
unknown113%
completed338%
withdrawn113%

Recent Activity

3 active trials
Showing 5 of 8
completedphase_4

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

NCT05009862
completedphase_2

Aspirin Resistance in Trinidad.

NCT06228820
recruitingphase_2

Aspirin for Postpartum Patients With Preeclampsia

NCT05924971
completedphase_4

Postpartum ASA and NT-proBNP

NCT05889468
active_not_recruitingphase_4

Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients

NCT05514847
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05009862Phase 4

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

Completed
NCT06228820Phase 2

Aspirin Resistance in Trinidad.

Completed
NCT05924971Phase 2

Aspirin for Postpartum Patients With Preeclampsia

Recruiting
NCT05889468Phase 4

Postpartum ASA and NT-proBNP

Completed
NCT05514847Phase 4

Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients

Active Not Recruiting
NCT05104229Phase 3

SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery

Withdrawn
NCT06165068Phase 3

Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study

Recruiting
NCT04872283Phase 3

Effect of Postoperative Ketorolac on Bone Healing After Joint Fusion

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8